En Carta Diagnostics
PrivateLast Round
Seed
Jul 10, 2026
Est. Valuation
$33M
Total Funding Raised
$7.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
En Carta Diagnostics is a biotechnology company that develops rapid point-of-care molecular diagnostic kits with an initial focus on the early diagnosis of Lyme disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Telemedicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
En Carta Diagnostics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
En Carta Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2026 | ||||
| Pre Seed | May 22, 2024 |
En Carta Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paris Biotech Santé | Pre Seed |
| 50 Partners | Pre Seed, Seed |
| Blue Forest Ventures | Seed |
| CentraleSupélec Venture | Seed, Pre Seed |
| Ring Capital | Seed |
| Bpifrance | Seed |
| PC'up Incubator | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 545% MoM.
- May 3, 2025
Monthly visitors increased 55% MoM.
En Carta Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about En Carta Diagnostics's valuation, stock price, and market status.